Literature DB >> 4582640

Quantitation of immunoglobulin-bearing lymphocytes and lymphocyte response to mitogens in horses persistently infected by equine infectious anemia virus.

K L Banks, J B Henson.   

Abstract

A defect in lymphocyte function could be responsible for persistent infection by the equine infectious anemia virus. The number of lymphocytes bearing surface immunoglobulin, as detected by immunofluorescence, and lymphocyte response to mitogens were the same in uninfected and equine infectious anemia-infected animals. A defect in T or B lymphocyte numbers or ability to respond to stimuli was not detected in this chronic virus disease.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4582640      PMCID: PMC422911          DOI: 10.1128/iai.8.4.679-682.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

Review 1.  Interaction between lymphocytes in immune responses.

Authors:  J F Miller; A Basten; J Sprent; C Cheers
Journal:  Cell Immunol       Date:  1971-10       Impact factor: 4.868

2.  Immunoglobulins on the surface of lymphocytes. 3. Bursal origin of surface immunoglobulins on chicken lymphocytes.

Authors:  E Rabellino; H M Grey
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

3.  Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis.

Authors:  F T Willems; J L Melnick; W E Rawls
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus.

Authors:  R J Howard; A L Notkins; S E Mergenhagen
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

6.  Cellular immunity in host resistance to viral infections.

Authors:  L A Glasgow
Journal:  Arch Intern Med       Date:  1970-07

7.  Two distinct populations of peripheral lymphocytes in mice distinguishable by immunofluorescence.

Authors:  M C Raff
Journal:  Immunology       Date:  1970-10       Impact factor: 7.397

8.  Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells.

Authors:  M B Oldstone; F J Dixon
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

9.  Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.

Authors:  G Janossy; M F Greaves
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

10.  Abnormalities of in vitro lymphocyte responses during rubella virus infections.

Authors:  G B Olson; P B Dent; W E Rawls; M A South; J R Montgomery; J L Melnick; R A Good
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more
  5 in total

1.  T and B lymphocytes in horses persistently infected with equine infectious anaemia virus.

Authors:  I Valpotić; M Kastelan; M Rudolf; M Gerencer; B Jukić; I Basić
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

2.  Suppression of synthesis of an IgG subclass in a persistent viral infection.

Authors:  T C McGuire
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

3.  Antigenic stimulation of T lymphocytes in chronic nononcogenic retrovirus infection: equine infectious anemia.

Authors:  M A Shively; K L Banks; A Greenlee; P Klevjer-Anderson
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Lymphocyte stimulation response in horses against phytohaemagglutinin and M protein of Streptococcus equi using whole blood.

Authors:  S K Srivastava; D A Barnum
Journal:  Can J Comp Med       Date:  1982-01

Review 5.  The immunopathogenesis of equine infectious anemia virus.

Authors:  D C Sellon; F J Fuller; T C McGuire
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.